Menu
Rajvir Dahiya has several patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
Patent number: 10822661
Abstract: A multi-gene-based assay for analysis of the following: (a) oncogene expression; (b) DNA methylation of tumor suppressor genes; (c) non-coding RNA expression (microRNA profiling); and (d) long non-coding RNA expression in cancer samples is disclosed. The assay method and device for conducting the assay are applicable to diagnosis, prognosis, and treatment of various cancers such as lung, breast, colorectal, prostate, liver, bladder; kidney, cervix, pancreatic, gastric, brain, oral, endometrium, and ovary. The assay methods find use in avoidance or postponement of surgical removal of cancer tissue.
Type: Grant
Filed: September 3, 2015
Date of Patent: November 3, 2020
Assignee: MIODx
Inventors: Rajvir Dahiya, M. Allen Northrup
Patent number: 10801072
Abstract: A multi-gene-based assay for analysis of the following: (a) oncogene expression; (b) DNA methylation of tumor suppressor genes; (c) non-coding RNA expression (microRNA profiling); and (d) long non-coding RNA expression in cancer samples is disclosed. The assay method and device for conducting the assay are applicable to diagnosis, prognosis, and treatment of various cancers such as lung, breast, colorectal, prostate, liver, bladder; kidney, cervix, pancreatic, gastric, brain, oral, endometrium, and ovary. The assay methods allow avoidance of surgery to remove cancerous tissue.
Type: Grant
Filed: September 3, 2015
Date of Patent: October 13, 2020
Assignee: MIODx
Inventors: Rajvir Dahiya, M. Allen Northrup
Publication number: 20170275702
Abstract: A multi-gene-based assay for analysis of the following: (a) oncogene expression; (b) DNA methylation of tumor suppressor genes; (c) non-coding RNA expression (microRNA profiling); and (d) long non-coding RNA expression in cancer samples is disclosed. The assay method and device for conducting the assay are applicable to diagnosis, prognosis, and treatment of various cancers such as lung, breast, colorectal, prostate, liver, bladder; kidney, cervix, pancreatic, gastric, brain, oral, endometrium, and ovary. The assay methods allow avoidance of surgery to remove cancerous tissue.
Type: Application
Filed: September 3, 2015
Publication date: September 28, 2017
Applicant: MIODx
Inventors: Rajvir DAHIYA, M. Allen NORTHRUP
Publication number: 20170233825
Abstract: A multi-gene-based assay for analysis of the following: (a) oncogene expression; (b) DNA methylation of tumor suppressor genes; (c) non-coding RNA expression (microRNA profiling); and (d) long non-coding RNA expression in cancer samples is disclosed. The assay method and device for conducting the assay are applicable to diagnosis, prognosis, and treatment of various cancers such as lung, breast, colorectal, prostate, liver, bladder; kidney, cervix, pancreatic, gastric, brain, oral, endometrium, and ovary. The assay methods find use in avoidance or postponement of surgical removal of cancer tissue.
Type: Application
Filed: September 3, 2015
Publication date: August 17, 2017
Applicant: MIODx
Inventors: Rajvir DAHIYA, M. Allen NORTHRUP
Patent number: 10822661
Abstract: A multi-gene-based assay for analysis of the following: (a) oncogene expression; (b) DNA methylation of tumor suppressor genes; (c) non-coding RNA expression (microRNA profiling); and (d) long non-coding RNA expression in cancer samples is disclosed. The assay method and device for conducting the assay are applicable to diagnosis, prognosis, and treatment of various cancers such as lung, breast, colorectal, prostate, liver, bladder; kidney, cervix, pancreatic, gastric, brain, oral, endometrium, and ovary. The assay methods find use in avoidance or postponement of surgical removal of cancer tissue.
Type: Grant
Filed: September 3, 2015
Date of Patent: November 3, 2020
Assignee: MIODx
Inventors: Rajvir Dahiya, M. Allen Northrup
Patent number: 9297008
Abstract: The present invention provides compositions, pharmaceutical preparations, kits and methods for increasing expression of a gene product in a cell by contacting the cell with a small activating RNA (saRNA) molecule comprising a ribonucleic strand that is complementary to a non-coding nucleic acid sequence of the gene.
Type: Grant
Filed: October 1, 2014
Date of Patent: March 29, 2016
Assignee: The Regents of the University of California
Inventors: Longcheng Li, Rajvir Dahiya
Publication number: 20150104869
Abstract: The present invention provides compositions, pharmaceutical preparations, kits and methods for increasing expression of a gene product in a cell by contacting the cell with a small activating RNA (saRNA) molecule comprising a ribonucleic strand that is complementary to a non-coding nucleic acid sequence of the gene.
Type: Application
Filed: October 1, 2014
Publication date: April 16, 2015
Inventors: Longcheng Li, Rajvir Dahiya
Patent number: 8877721
Abstract: The present invention provides compositions, pharmaceutical preparations, kits and methods for increasing expression of a gene product in a cell by contacting the cell with a small activating RNA (saRNA) molecule comprising a ribonucleic strand that is complementary to a non-coding nucleic acid sequence of the gene.
Type: Grant
Filed: April 11, 2006
Date of Patent: November 4, 2014
Assignee: The Regents of the University of California
Inventors: Longcheng Li, Rajvir Dahiya
Publication number: 20110054012
Abstract: The present invention provides compositions, pharmaceutical preparations, kits and methods for increasing expression of a gene product in a cell by contacting the cell with a microRNA (miRNA) molecule comprising a ribonucleic strand that is complementary to a non-coding nucleic acid sequence of the gene.
Type: Application
Filed: December 23, 2008
Publication date: March 3, 2011
Inventors: Robert F. Place, Long-Cheng Li, Rajvir Dahiya
Publication number: 20100210707
Abstract: The present invention provides compositions, pharmaceutical preparations, kits and methods for increasing expression of a gene product in a cell by contacting the cell with a small activating RNA (saRNA) molecule comprising a ribonucleic strand that is complementary to a non-coding nucleic acid sequence of the gene.
Type: Application
Filed: April 11, 2006
Publication date: August 19, 2010
Inventors: Longcheng Li, Rajvir Dahiya
Patent number: 7306627
Abstract: Acellular matrix grafts are provided with are isolated from natural sources and consist essentially of a collagen and elastin matrix which is devoid of cellular components. The grafts are useful scaffolds which promote the regeneration of muscle tissue and aid in restoring muscle function. Due to their acellular nature, the grafts lack antigenicity. As a result, the acellular matrix grafts can be isolated from autographic, allographic or xenographic tissues.
Type: Grant
Filed: January 18, 2002
Date of Patent: December 11, 2007
Assignee: The Regents of the University of California
Inventors: Emil A. Tanagho, Rajvir Dahiya, Tom F. Lue, Gerald R. Cunha
Publication number: 20020128711
Abstract: Acellular matrix grafts are provided with are isolated from natural sources and consist essentially of a collagen and elastin matrix which is devoid of cellular components. The grafts are useful scaffolds which promote the regeneration of muscle tissue and aid in restoring muscle function. Due to their acellular nature, the grafts lack antigenicity. As a result, the acellular matrix grafts can be isolated from autographic, allographic or xenographic tissues.
Type: Application
Filed: January 18, 2002
Publication date: September 12, 2002
Applicant: The Regents of the University of California
Inventors: Emil A. Tanagho, Rajvir Dahiya, Tom F. Lue, Gerald R. Cunha
Patent number: 6371992
Abstract: Acellular matrix grafts are provided with are isolated from natural sources and consist essentially of a collagen and elastin matrix which is devoid of cellular components. The grafts are useful scaffolds which promote the regeneration of muscle tissue and aid in restoring muscle function. Due to their acellular nature, the grafts lack antigenicity. As a result, the acellular matrix grafts can be isolated from autographic, allographic or xenographic tissues.
Type: Grant
Filed: December 19, 1997
Date of Patent: April 16, 2002
Assignee: The Regents of the University of California
Inventors: Emil A. Tanagho, Rajvir Dahiya, Tom F. Lue, Gerald R. Cunha
Patent number: 5656478
Abstract: The present invention provides a method of growing smooth muscle cells in a host with the purpose of maintaining natural cellular function by the function of smooth muscle tissue. In this method, smooth muscle cells are freed from isolated smooth muscle tissue then cultured and injected into the host in combination with an extracellular matrix.
Type: Grant
Filed: February 25, 1994
Date of Patent: August 12, 1997
Assignee: The Regents of the University of California
Inventors: Emil A. Tanagho, Rajvir Dahiya, Tom F. Lue, Gerald R. Cunha
3517 Breakwater Ave
Hayward, CA 94545
© 2024 GeneVerify Inc.